14% of Maryland nursing care residents who died from COVID-19
were asymptomatic at initial testing

A large-cohort nursing home study during the COVID-19 pandemic evaluated the outcomes of 1,970 residents from 15 nursing home facilities with universal testing in Maryland.

The study used descriptive statistics to compare baseline characteristics, logistic regression to assess the association of comorbidities with COVID-19, and Cox regression to assess the association of asymptomatic and symptomatic COVID-19 with mortality and hospitalization. The study also assessed the association of comorbidities with mortality and hospitalization risk and symptom status was assessed at the time of the first test with a maximum follow-up of 94 days.

The study concluded:

Asymptomatic infection has profound implications in this population as there was a higher risk of death, but not hospitalization
More than half of the cases detected were asymptomatic at testing, which is consistent with other early reports in this setting
Residents who are asymptomatic, and test positive, have up to 2 times the mortality risk of residents who test negative for SARS-CoV-2

At a Glance

1970

residents

Study included one of the largest cohort of nursing homes residents with individual-level data

242

There were 242 deaths among the 1,970 residents over the 94-day follow-up period

14 %

14% of individuals who died were asymptomatic but tested positive

To Read The Full Study: Click Here

Source: Tang, O & Bigelow, BF et al. "Outcomes of Nursing Home COVID-19 Patients by Initial Symptoms and Comorbidity: Results of Universal Testing of 1970 Residents." December 2020. Journal of the American Medical Directors Association. https://www.jamda.com/article/S1525-8610(20)30887-2/fulltext

Disclaimer: Scientific articles are presented for educational purposes only and are not intended to promote any Beckman Coulter product or service. Opinions and conclusions are those of the respective authors and not Beckman Coulter.

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

© 2024 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.

Choose your country/region and language

Country or Region

Language

14% of Maryland nursing care residents who died from COVID-19 were asymptomatic at initial testing

At a Glance

To Read The Full Study: Click Here

14% of Maryland nursing care residents who died from COVID-19
were asymptomatic at initial testing